James Edgemond serves as Executive at UNITED THERAPEUTICS Corp, where they oversee executive responsibilities. Since joining the company, James Edgemond has executed 138 insider transactions totaling $87.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 9, 2024 involved exercising options for 850 shares valued at $100.1K.
James Edgemond currently holds 9,018 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Edgemond has been a net seller of UTHR stock. They have purchased $0 and sold $87.5M worth of shares.
James Edgemond's most recent insider trade was on Sep 9, 2024, when they sold 850 shares at $117.76 per share.
Get notified when new Form 4 filings are submitted
| $345.41 |
| Planned |
| Sep 9, 2024 | UTHR | $98.1K | Option Exercise | 816 | $120.26 | Planned |
| Sep 9, 2024 | UTHR | $392.8K | Option Exercise | 3,266 | $120.26 | Planned |
| Sep 9, 2024 | UTHR | $400.4K | Option Exercise | 3,400 | $117.76 | Planned |
| Sep 9, 2024 | UTHR | $1.2M | Sale | 3,400 | $345.41 | Planned |
| Sep 3, 2024 | UTHR | $400.4K | Option Exercise | 3,400 | $117.76 | Planned |
| Sep 3, 2024 | UTHR | $1.2M | Sale | 3,266 | $362.37 | Planned |
| Sep 3, 2024 | UTHR | $98.1K | Option Exercise | 816 | $120.26 | Planned |
| Sep 3, 2024 | UTHR | $1.2M | Sale | 3,400 | $362.37 | Planned |
| Sep 3, 2024 | UTHR | $392.8K | Option Exercise | 3,266 | $120.26 | Planned |
| Sep 3, 2024 | UTHR | $199.3K | Sale | 550 | $362.37 | Planned |
| Sep 3, 2024 | UTHR | $100.1K | Option Exercise | 850 | $117.76 | Planned |
| Sep 3, 2024 | UTHR | $206.2K | Sale | 569 | $362.37 | Planned |
| Aug 26, 2024 | UTHR | $100.1K | Option Exercise | 850 | $117.76 | Planned |
| Aug 26, 2024 | UTHR | $392.8K | Option Exercise | 3,266 | $120.26 | Planned |
| Aug 26, 2024 | UTHR | $1.1M | Sale | 3,266 | $347.60 | Planned |
| Aug 26, 2024 | UTHR | $400.4K | Option Exercise | 3,400 | $117.76 | Planned |
| Aug 26, 2024 | UTHR | $98.1K | Option Exercise | 816 | $120.26 | Planned |
| Aug 26, 2024 | UTHR | $193.6K | Sale | 557 | $347.60 | Planned |
| Aug 26, 2024 | UTHR | $200.2K | Sale | 576 | $347.60 | Planned |
| Aug 26, 2024 | UTHR | $1.2M | Sale | 3,400 | $347.60 | Planned |
| Aug 19, 2024 | UTHR | $1.1M | Sale | 3,400 | $329.02 | Planned |
| Aug 19, 2024 | UTHR | $392.8K | Option Exercise | 3,266 | $120.26 | Planned |
| Aug 19, 2024 | UTHR | $1.1M | Sale | 3,266 | $329.02 | Planned |
| Aug 19, 2024 | UTHR | $400.4K | Option Exercise | 3,400 | $117.76 | Planned |
| Aug 19, 2024 | UTHR | $98.1K | Option Exercise | 816 | $120.26 | Planned |
| Aug 19, 2024 | UTHR | $194.5K | Sale | 591 | $329.02 | Planned |
| Aug 19, 2024 | UTHR | $100.1K | Option Exercise | 850 | $117.76 | Planned |
| Aug 19, 2024 | UTHR | $187.9K | Sale | 571 | $329.02 | Planned |